高銀金融(00530.HK)稱呈請人尋求將公司清盤並不適宜
格隆匯10月16日丨高銀金融(00530.HK)發佈公告,公司及若干直接及間接附屬公司於2020年7月13日分別接獲數份通知,內容關於賜譽有限公司(公司間接全資附屬公司)、成美控股有限公司及Goal Eagle Limited(兩者均為公司的直接全資附屬公司)結欠的若干債務。
公司將於2020年10月30日舉行的押後進行的呈請聆訊中,對該呈請積極抗辯。公司已於2020年10月15日,向法院提交為該呈請進行抗辯及反對對公司授出清盤令的誓章。公司認為,呈請人尋求將公司清盤並不適宜,且對公司進行清盤的理由缺乏理據,因此,公司可能於該呈請抗辯中獲勝。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.